Abstract:Compared to the conventional anti-cancer drugs, the nano-drug delivery systems (NDDS) shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity and efficient drug release ability. In this study, a novel macromolecular prodrug conjugate was designed and developed that is passively triggered by the acidic environment of the tumor cells and can release doxorubicin (Dox). The susceptibility of the system to the acidic environment is due to the acid volatile Schiff base covalent bond between grafted carboxymethyl chitosan (CMCs) and Dox. The chemical structure of the finalized system was characterized by 1H-NMR spectroscopy. Because of the hydrophobicity of the Dox and the hydrophilicity of the CMCs, the amphipathic polymeric drug conjugates can self-assemble into the nanoparticles in aqueous solution. The morphology and size of the nanoparticles were observed with TEM (transmission electron microscopy) and DLS (dynamic light scattering). The in vitro drug release studies demonstrated that the drug release rate of the prodrug were visibly higher in acidic conditions (pH 5.0) compared to higher pHs like 6.5 and 7.4. DLS results showed that the mean size of the prodrug nanoparticles increased as the pH of the solution decreased from 7.4 to 6.5 and 5.0. Furthermore, the cell counting kit-8 (CCK-8) assays showed that the polymeric drug nanoparticles had a cytotoxic effect on SKOV3 ovarian cancer cells while the segments of the DDS revealed comparatively lower cytotoxic effect. Moreover, confocal laser scanning microscopy (CLSM) showed that the prodrug could efficiently deliver and release Dox in the nuclei of the cancer cells while this was not observed for the Dox pure drug. These results proved that the carboxymethyl chitosan-CBA-Doxorubicin NPs have superior stabilities, low toxicities, proper sizes, and enhanced curable efficiency for in vitro controlled release. Thus, this pH-sensitive prodrug could be a potential treatment for cancer therapy in the near future.

Chitosan-coated nanodiamonds: Mucoadhesive platform for intravesical delivery of doxorubicin

Chitosan-Alginate Nanoparticle System Efficiently Delivers Doxorubicin to MCF-7 Cells

Surface Charge Effect on Mucoadhesion of Chitosan Based Nanogels for Local Anti-Colorectal Cancer Drug Delivery.

Control of Nanodiamond-Doxorubicin Drug Loading and Elution Through Optimized Compositions and Release Environments

Folic Acid–Chitosan Oligosaccharide Conjugates Decorated Nanodiamond As Potential Carriers for the Oral Delivery of Doxorubicin

Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

Ph-Sensitive Chitosan-Derived Nanoparticles As Doxorubicin Carriers for Effective Anti-Tumor Activity: Preparation and in Vitro Evaluation.

Bioadhesive chitosan-coated cyclodextrin-based superamolecular nanomicelles to enhance the oral bioavailability of doxorubicin

Smart chitosan nanogel for targeted doxorubicin delivery, ensuring precise release, and minimizing side effects in Ehrlich ascites carcinoma-bearing mice

Multilayer Sodium Alginate Beads with Porous Core Containing Chitosan Based Nanoparticles for Oral Delivery of Anticancer Drug

Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation via Thiol-Maleimide Click Reaction for Intravesical Drug Delivery

Towards more efficient inhalable chemotherapy: Fabrication of nanodiamonds-releasing microspheres

Synthesis and Characterization of Nanodiamond-Doxorubicin (Dox) Conjugate for Effective Delivery against MCF-7 Cell Lines

PolyPEGylated Nanodiamond for Intracellular Delivery of a Chemotherapeutic Drug

Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation

Doxorubicin-loaded Mn-doped SiO2 Nanospheres Coated with Carboxymethyl Chitosan: Fabrication, Characterization, and in Vitro Evaluation

Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.

Functionalized Mesoporous Silica Nanoparticles with Mucoadhesive and Sustained Drug Release Properties for Potential Bladder Cancer Therapy.

Efficient Intravesical Therapy of Bladder Cancer with Cationic Doxorubicin Nanoassemblies

Synthesis and Evaluation of Ph-Sensitive, Self-Assembled Chitosan-Based Nanoparticles As Efficient Doxorubicin Carriers